Inspire Medical Systems, Inc.

Valuation Analysis

About the Company

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc. Stock at a Glance

Inspire Medical Systems, Inc. (INSP) is currently trading at $42.70 with a market capitalization of $1.2B. The trailing P/E ratio stands at 9.7x, with a forward P/E of 32.71x. The 52-week range spans from $38.91 to $147.03; the current price is 71% below the yearly high. Year-over-year revenue growth stands at +1.6%. The net profit margin stands at 14.33%.

💰 Dividend

Inspire Medical Systems, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

12 analysts rate Inspire Medical Systems, Inc. (INSP) on consensus: None. The average price target is $52.17, implying +22.17% from the current price. Analyst price targets range from $39.00 to $65.00.

Inspire Medical Systems, Inc.: The Investment Case in Detail

Inspire Medical Systems, Inc. (INSP) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

With a gross margin near 85.78%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

The Bear Case

Revenue growth has slowed to just 1.6%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Short interest sits at 16.81% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

What to Watch Next

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 22.17% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (16.81%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Inspire Medical Systems, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.